Arti Ahluwalia
Career history of Arti Ahluwalia
Former positions of Arti Ahluwalia
Companies | Position | Start | End |
---|---|---|---|
University of Pisa | Corporate Officer/Principal | - | - |
Tissue Engineering Technologies AG
Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Corporate Officer/Principal | - | - |
Kirkstall Ltd.
Kirkstall Ltd. Pharmaceuticals: OtherHealth Technology Kirkstall Ltd. provides in vitro cell culture research and the development services. Its products include cancer research, stem cell research, disease modeling, drug discovery and advanced organ models. The company was founded by J. Malcolm Wilkinson, Garry P. Mumford, and Arti Ahluwalia on November 23, 2006 and is headquartered in Rotherham, the United Kingdom. | Chief Tech/Sci/R&D Officer | 22/06/2010 | 23/01/2014 |
Founder | 22/11/2000 | - |
Statistics
International
United Kingdom | 2 |
Italy | 2 |
Germany | 2 |
Operational
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Kirkstall Ltd.
Kirkstall Ltd. Pharmaceuticals: OtherHealth Technology Kirkstall Ltd. provides in vitro cell culture research and the development services. Its products include cancer research, stem cell research, disease modeling, drug discovery and advanced organ models. The company was founded by J. Malcolm Wilkinson, Garry P. Mumford, and Arti Ahluwalia on November 23, 2006 and is headquartered in Rotherham, the United Kingdom. | Health Technology |
Tissue Engineering Technologies AG
Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Health Technology |
- Stock Market
- Insiders
- Arti Ahluwalia
- Experience